DY-9760e, a novel calmodulin antagonist with cytoprotective action

By Sugimura M.   Sato T.   Nakayama W.   Morishima Y.   Fukunaga K.   Omitsu M.   Miyamoto E.   Shirasaki Y.  

European Journal of Pharmacology, Vol. 336, Iss. 1, 1997-10 ,pp. : 99-106

Elsevier

Access to resources Recommend Favorite

DY-9760e, a novel calmodulin antagonist, reduces brain damage induced by transient focal cerebral ischemia

By Sato T.   Morishima Y.   Sugimura M.   Uchida T.   Shirasaki Y.  

European Journal of Pharmacology, Vol. 370, Iss. 2, 1999-04 ,pp. : 117-123

Elsevier

Access to resources Recommend Favorite

Erratum to `Interactions of agonists with an allosteric antagonist at muscarinic acetylcholine M 2 receptors' - [Eur. J. Pharmacol. 316 (1996) 27-32]

By Lanzafame A.   Christopoulos A.   Mitchelson F.  

European Journal of Pharmacology, Vol. 321, Iss. 3, 1997-03 ,pp. : 399-399

Elsevier

Access to resources Recommend Favorite

Erratum to: ''The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK 1 receptor'' [Eur. J. Pharmacol. 400 (2000) 185-194]

By Gouldson P.   Legoux P.   Carillon C.   Delpech B.   Le Fur G.   Ferrara P.   Shire D.  

European Journal of Pharmacology, Vol. 407, Iss. 3, 2000-11 ,pp. : 333-333

Elsevier

Access to resources Recommend Favorite

Erratum to ''CP8668, a novel orally active nonsteroidal progesterone receptor modulator with tetrahydrobenzindolone skeleton'' [Eur. J. Pharmacol. 461 (2003) 73-78]

By Tabata Y.   Iizuka Y.   Shinei R.   Kurihara K.-i.   Okonogi T.   Hoshiko S.   Kurata Y.  

European Journal of Pharmacology, Vol. 465, Iss. 3, 2003-04 ,pp. : 299-299

Elsevier

Access to resources Recommend Favorite